Relationship of Serum Zinc Level With Severity of Diabetic Nephropathy
ConditionDiabetic Nephropathy Type 2
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssiut University
About this trial
Zinc influences the production and action of erythropoietin (EPO), a hormone produced by the kidneys that stimulates red blood cell production.
However, further research is needed to fully understand the mechanisms and to develop evidence-based guidelines for zinc supplementation in patient with Diabetic kidney disease. this study aim to detect serum zinc level in patient with Diabetic kidney disease "CKD" and Study of association between serum zinc and serum urea, creatinine, GFR, hemoglobin ,HbA1c in DKD
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with diabetic kidney disease
Disqualifiers
patients on dialysis. Patient refuse to participate
Other renal disease "lupus nephritis,GlomeruloNephritis
Trial population
Patients with diabetic kidney disease and Diabetic patient without kidney disease as a control
Trial design
Design model
Cohort
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
92 Participants
are grouped into 2 trial groupsGroup A: group 1
Group B: group 2
Trial outcomes
Primary outcomes
1
zinc level
prevalence of hypozincemia in Diabetic kidney disease
Time frame
baselineLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: